Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial.
Biotech company Moderna said the first phase of trials for a COVID-19 vaccine was tested on 45 human volunteers.
Early data shows eight of the volunteers developed a type of...
A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse..
AstraZeneca expects to be able to deliver a billion doses of a possible COVID-19 vaccine this year and next if tests are successful, adding on Thursday it should shortly get results of an early stage..